X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (306) 306
Conference Proceeding (7) 7
Magazine Article (5) 5
Book Review (2) 2
Book / eBook (1) 1
Dissertation (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (143) 143
melanoma (91) 91
female (88) 88
male (86) 86
oncology (75) 75
middle aged (68) 68
adult (67) 67
aged (58) 58
melanoma - drug therapy (54) 54
dermatology (51) 51
metastasis (40) 40
cancer (39) 39
skin neoplasms - pathology (38) 38
survival (38) 38
ipilimumab (37) 37
skin neoplasms - drug therapy (36) 36
treatment outcome (35) 35
aged, 80 and over (34) 34
care and treatment (32) 32
melanoma - pathology (31) 31
immunotherapy (27) 27
neoplasm staging (27) 27
clinical trials (26) 26
antineoplastic agents - therapeutic use (25) 25
hematology, oncology and palliative medicine (25) 25
mutation (24) 24
patients (24) 24
prognosis (24) 24
analysis (23) 23
disease-free survival (23) 23
risk factors (23) 23
young adult (23) 23
cutaneous melanoma (22) 22
double-blind method (22) 22
metastases (22) 22
quality of life (22) 22
life sciences (21) 21
nivolumab (21) 21
therapy (20) 20
adolescent (19) 19
melanoma - mortality (19) 19
research (19) 19
abridged index medicus (18) 18
diagnosis (18) 18
malignant-melanoma (18) 18
chemotherapy (17) 17
tumors (17) 17
antibodies, monoclonal - adverse effects (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (16) 16
melanoma - genetics (16) 16
melanoma - secondary (16) 16
metastatic melanoma (16) 16
retrospective studies (16) 16
studies (16) 16
vemurafenib (16) 16
medicine, general & internal (15) 15
skin cancer (15) 15
proto-oncogene proteins b-raf - genetics (14) 14
skin neoplasms - diagnosis (14) 14
skin neoplasms - mortality (14) 14
time factors (14) 14
antineoplastic agents - adverse effects (13) 13
kaplan-meier estimate (13) 13
pembrolizumab (13) 13
skin neoplasms - therapy (13) 13
survival analysis (13) 13
drug therapy (12) 12
follow-up studies (12) 12
high-risk melanoma (12) 12
melanoma - diagnosis (12) 12
melanoma - surgery (12) 12
multicenter (12) 12
prospective studies (12) 12
usage (12) 12
antibodies, monoclonal - therapeutic use (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (11) 11
biochemistry (11) 11
dabrafenib (11) 11
disease progression (11) 11
drug dosages (11) 11
immune checkpoint (11) 11
surgery (11) 11
braf (10) 10
cell biology (10) 10
human health and pathology (10) 10
immunology (10) 10
molecular biology (10) 10
pd-1 protein (10) 10
skin neoplasms - genetics (10) 10
skin neoplasms - surgery (10) 10
antibodies, monoclonal - administration & dosage (9) 9
cancer therapies (9) 9
double-blind (9) 9
interferon (9) 9
medical research (9) 9
melanoma - therapy (9) 9
patient outcomes (9) 9
skin (9) 9
adjuvant therapy (8) 8
algorithms (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, ISSN 0151-9638, 05/2010, Volume 137, pp. 18 - 18
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 7, pp. 863 - 873
Summary Background Dabrafenib plus trametinib improves clinical outcomes in BRAFV600 -mutant metastatic melanoma without brain metastases; however, the... 
Hematology, Oncology and Palliative Medicine
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 19, pp. 1824 - 1835
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 19, pp. 1789 - 1801
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 4, pp. 375 - 384
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 386, Issue 9992, pp. 444 - 451
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 12, pp. 1743 - 1754
Summary Background Dabrafenib plus trametinib treatment provides significant benefits over BRAF-inhibitor monotherapy in patients with BRAFV600E -mutant or... 
Hematology, Oncology and Palliative Medicine | UNTREATED MELANOMA | BRAF INHIBITION | METASTATIC MELANOMA |